bergenin has been researched along with Diabetic Glomerulosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Hao, H; Quan, Y; Shangguan, C; Su, P; Yue, L | 1 |
| Dai, Y; Liu, R; Lv, C; Miao, Y; Qiao, S; Tao, Y; Wei, Z; Xia, Y; Yue, M | 1 |
| Kan, M; Wu, GY; Yang, J | 1 |
3 other study(ies) available for bergenin and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Bergenin ameliorates diabetic nephropathy in C57BL/6 J mice by TLR4/MyD88/NF-κB signalling pathway regulation.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4 | 2023 |
Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway.
Topics: Animals; Benzopyrans; beta-Transducin Repeat-Containing Proteins; Diabetic Nephropathies; Extracellular Matrix; Humans; Mesangial Cells; Mice; Mice, Inbred NOD; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
Topics: Animals; Benzopyrans; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Inflammation; Male; Mesangial Cells; Rats; Rats, Wistar; Smad Proteins; Transforming Growth Factor beta1 | 2016 |